Xcout Intel
Dash Bio
Dash Bio, Inc. is a biotechnology company founded in 2024 with its headquarters located in Boston, Massachusetts.
Subscribe to see Dash Bio’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Dash Bio at a glance
Dash Bio is a biotech company headquartered in United States. It has raised at least $47.5M across the 3 funding rounds on record. Its most recent funding round, Series A, raised $30M in August 2026. Xcout tracks 9 named people at Dash Bio, including Dave Johnson (Chief Executive Officer).
Dash Bio leadership
- Dave JohnsonChief Executive Officer
- David JohnsonPRESIDENT AND CEO
- Ander TallettChief Operating Officer
- Ely PorterChief Scientific Officer
- Dave Johnsonco-founder
- ALEXANDER TALLETTExecutive Officer
3 more named people on record for Dash Bio, with roles, board committees and tenure — see the full roster →
Dash Bio funding rounds
At least $47.5M raised across the 3 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $30M | 1 named | |
| SEC Form D filing | $11M | — | |
| Series A | $6.5M | 3 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Recent Dash Bio news
Investors
Dash Bio competitors
A few of Dash Bio's closest competitors — see the full list of competitors and alternatives →
Korsana Biosciences is a private biotechnology research company founded in 2024 and headquartered in Waltham, Massachusetts.
Exsilio Therapeutics Inc. is a biotechnology company headquartered in Boston, Massachusetts, founded in 2022 to pioneer genomic medicines and advanced genetic therapies.
Signify Bio is a biotechnology company established in 2024 and based in Dallas, Texas, that is transforming the development of in situ protein therapeutics by harnessing the human body's natural capabilities.
Bambusa Therapeutics is a biotechnology research company with roots in Victoria, Australia, and an office in Boston, Massachusetts. It focuses on biotech research and development.
Delphia Therapeutics is a biotechnology research company headquartered in Cambridge, Massachusetts, with a team of 11 to 50 employees focused on therapeutic innovations.
Expedition Medicines, Inc. is a biotechnology company founded in 2022 and headquartered in Cambridge, Massachusetts, focused on generatively designing novel drugs targeting specific proteins.
Get Dash Bio's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Dash Bio in Xcout Intel
- 9 named people with titles, LinkedIn and board committees
- 3 funding rounds with the investors in each, and who they co-invest with
- 1 corporate event with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access